(Q51574619)

7 April 2018

title

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. (English)

1 reference

7 April 2018

0 references

0 references

Ueno T

1

1 reference

7 April 2018

Sugawara H

2

1 reference

7 April 2018

Sujaku K

3

1 reference

7 April 2018

Hashimoto O

4

1 reference

7 April 2018

Tsuji R

5

1 reference

7 April 2018

Tamaki S

6

1 reference

7 April 2018

Torimura T

7

1 reference

7 April 2018

Inuzuka S

8

1 reference

7 April 2018

Sata M

9

1 reference

7 April 2018

Tanikawa K

10

1 reference

7 April 2018

publication date

1 July 1997

1 reference

7 April 2018

published in

Journal of Hepatology

1 reference

7 April 2018

volume

27

1 reference

7 April 2018

page(s)

103-107

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Health implications of overweight and obesity in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Fatty liver hepatitis and cirrhosis in obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Nonalcoholic steatohepatitis: an expanded clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Very-low-calorie-diet therapy in severe obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Energy expenditure in obese women before and during weight loss, after refeeding, and in the weight-relapse period.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Severe vs moderate energy restriction with and without exercise in the treatment of obesity: efficiency of weight loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Indices of relative weight and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Effects of weight changes produced by exercise, food restriction, or overeating on body composition

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Hepatic free fatty acids in alcoholic liver disease and morbid obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980287-5

7 January 2021

10.1016/S0168-8278(97)80287-5

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

9252081

1 reference

7 April 2018